Cargando…
Fungal Secondary Metabolite Exophillic Acid Selectively Inhibits the Entry of Hepatitis B and D Viruses
Current anti-hepatitis B virus (HBV) drugs are suppressive but not curative for HBV infection, so there is considerable demand for the development of new anti-HBV agents. In this study, we found that fungus-derived exophillic acid inhibits HBV infection with a 50% maximal inhibitory concentration (I...
Autores principales: | Kobayashi, Chisa, Watanabe, Yoshihiro, Oshima, Mizuki, Hirose, Tomoyasu, Yamasaki, Masako, Iwamoto, Masashi, Iwatsuki, Masato, Asami, Yukihiro, Kuramochi, Kouji, Wakae, Kousho, Aizaki, Hideki, Muramatsu, Masamichi, Sureau, Camille, Sunazuka, Toshiaki, Watashi, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026752/ https://www.ncbi.nlm.nih.gov/pubmed/35458494 http://dx.doi.org/10.3390/v14040764 |
Ejemplares similares
-
Troglitazone Impedes the Oligomerization of Sodium Taurocholate Cotransporting Polypeptide and Entry of Hepatitis B Virus Into Hepatocytes
por: Fukano, Kento, et al.
Publicado: (2019) -
Identification of Anti-Severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Oxysterol Derivatives In Vitro
por: Ohashi, Hirofumi, et al.
Publicado: (2021) -
A versatile method to profile hepatitis B virus DNA integration
por: Fukano, Kento, et al.
Publicado: (2023) -
Flap endonuclease 1 is involved in cccDNA formation in the hepatitis B virus
por: Kitamura, Kouichi, et al.
Publicado: (2018) -
Mefloquine, a Potent Anti-severe Acute Respiratory Syndrome-Related Coronavirus 2 (SARS-CoV-2) Drug as an Entry Inhibitor in vitro
por: Shionoya, Kaho, et al.
Publicado: (2021)